CoChat

Amyloid‐related imaging abnormalities from trials of solanezumab for Alzheimer's disease

Open access
Carlson, Christopher, Siemers, Eric, Hake, Ann, Case, Michael, Hayduk, Roza, Suhy, Joyce, Oh, Joonmi, Barakos, Jerome · 2016 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Cited by 65

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Introduction: Solanezumab, a humanized monoclonal antibody that binds soluble amyloid beta peptide, is being developed for treatment of Alzheimer's disease (AD). Methods: Patients (n = 2042) with mild and moderate AD were randomized 1:1 to 400‐mg solanezumab or placebo infusion every 4 weeks for 80 weeks and 1457 patients entered an open‐label extension. Magnetic resonance imaging scans monitored for amyloid‐related imaging abnormalities‐edema/effusion (ARIA‐E) and amyloid‐related imaging abnormalities‐hemorrhage/hemosiderin deposition. Results: Sixteen patients (solanezumab, n = 11; placebo, n = 5) developed ARIA‐E during the double‐blind phase, and 7 patients developed ARIA‐E during the open‐label extension as of July 31, 2014. Unique cases are discussed including solanezumab patients who were given solanezumab, while ARIA‐E was present and a patient who developed ARIA‐E during placebo treatment and again during solanezumab treatment. Discussion: Asymptomatic ARIA‐E was detected in solanezumab‐treated and placebo‐treated AD patients. ARIA‐E occurs infrequently during solanezumab and placebo treatments but may occur repeatedly in some patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dadm.2016.02.004

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Carlson, C., Siemers, E., Hake, A., Case, M., Hayduk, R., Suhy, J., Oh, J., & Barakos, J.
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2016-01
Volume
2
Issue
1
Pages
75-85
ISSN
2352-8729 (ISSN-L)
OpenAlex
W2291453643
Cited by
65
References
10
FWCI
2.28
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.